MA53909A - Compositions et méthodes de stimulation ovarienne contrôlée - Google Patents

Compositions et méthodes de stimulation ovarienne contrôlée

Info

Publication number
MA53909A
MA53909A MA053909A MA53909A MA53909A MA 53909 A MA53909 A MA 53909A MA 053909 A MA053909 A MA 053909A MA 53909 A MA53909 A MA 53909A MA 53909 A MA53909 A MA 53909A
Authority
MA
Morocco
Prior art keywords
compositions
methods
ovarian stimulation
controlled ovarian
controlled
Prior art date
Application number
MA053909A
Other languages
English (en)
Other versions
MA53909B1 (fr
Inventor
Saez Joan-Carles Arce
Patrick Heiser
Lisbeth Helmgaard
Bjarke Mirner Klein
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of MA53909A publication Critical patent/MA53909A/fr
Publication of MA53909B1 publication Critical patent/MA53909B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
MA53909A 2018-10-17 2019-10-17 Compositions et méthodes de stimulation ovarienne contrôlée MA53909B1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862746812P 2018-10-17 2018-10-17
EP18203167 2018-10-29
EP19794444.0A EP3866833B1 (fr) 2018-10-17 2019-10-17 Compositions comprenant de la fsh recombinante pour le traitement de l'infertilité
PCT/EP2019/078170 WO2020079127A1 (fr) 2018-10-17 2019-10-17 Compositions et méthodes de stimulation ovarienne contrôlée

Publications (2)

Publication Number Publication Date
MA53909A true MA53909A (fr) 2022-01-26
MA53909B1 MA53909B1 (fr) 2025-07-31

Family

ID=68344788

Family Applications (1)

Application Number Title Priority Date Filing Date
MA53909A MA53909B1 (fr) 2018-10-17 2019-10-17 Compositions et méthodes de stimulation ovarienne contrôlée

Country Status (30)

Country Link
US (2) US12311012B2 (fr)
EP (2) EP3866833B1 (fr)
JP (2) JP7555915B2 (fr)
KR (1) KR20210079276A (fr)
CN (1) CN112789053A (fr)
AU (1) AU2019363279B2 (fr)
BR (1) BR112021005019A2 (fr)
CA (1) CA3110205A1 (fr)
CL (2) CL2021000928A1 (fr)
CO (1) CO2021005872A2 (fr)
DK (1) DK3866833T3 (fr)
ES (1) ES3026229T3 (fr)
FI (1) FI3866833T3 (fr)
HR (1) HRP20250463T1 (fr)
HU (1) HUE070973T2 (fr)
IL (1) IL280750A (fr)
JO (1) JOP20210025B1 (fr)
LT (1) LT3866833T (fr)
MA (1) MA53909B1 (fr)
MD (1) MD3866833T2 (fr)
MX (1) MX2021004383A (fr)
MY (1) MY210133A (fr)
PH (1) PH12021550417A1 (fr)
PL (1) PL3866833T3 (fr)
RS (1) RS66713B1 (fr)
SG (1) SG11202102340RA (fr)
SI (1) SI3866833T1 (fr)
TW (1) TWI846743B (fr)
UA (1) UA128731C2 (fr)
WO (1) WO2020079127A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020002235A (es) 2017-09-01 2020-07-20 Ferring Bv Composicion para la estimulacion ovarica controlada.
TW202237173A (zh) * 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04002257A (es) * 2001-09-12 2004-07-23 Applied Research Systems Uso de gonadotropina corionica humana (gch) y su hormona de liberacion (hl) en hiperestimulacion ovarica controlada.
EP1364658A1 (fr) * 2002-05-24 2003-11-26 Applied Research Systems ARS Holding N.V. Utilisation de rapports variables de gonadotrophines dans l'hyperstimulation ovarienne contrôlée
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
EP2717904A1 (fr) 2011-06-06 2014-04-16 Ferring BV Préparation pharmaceutique
JO3092B1 (ar) * 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
EP2956542A4 (fr) 2013-02-15 2016-09-14 Sungkwang Medical Foundation Production de cellules souches parthénogénétiques et de cellules souches embryonnaires humaines spécifiques d'un patient par transfert nucléaire de cellules somatiques
EP3283097B1 (fr) 2015-04-17 2020-02-12 Ferring B.V. Fsh pour le traitement de l'infertilité
MX2020002235A (es) 2017-09-01 2020-07-20 Ferring Bv Composicion para la estimulacion ovarica controlada.
HUE071268T2 (hu) 2018-04-30 2025-08-28 Ferring Bv Készítmény szabályozott petefészek-stimuláláshoz
TW202237173A (zh) 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法

Also Published As

Publication number Publication date
EP4516354A3 (fr) 2025-05-14
JP2022505191A (ja) 2022-01-14
CO2021005872A2 (es) 2021-09-20
FI3866833T3 (fi) 2025-05-21
PH12021550417A1 (en) 2021-09-20
TW202027780A (zh) 2020-08-01
HUE070973T2 (hu) 2025-07-28
TWI846743B (zh) 2024-07-01
KR20210079276A (ko) 2021-06-29
US12311012B2 (en) 2025-05-27
JP2024133520A (ja) 2024-10-02
RS66713B1 (sr) 2025-05-30
EP4516354A2 (fr) 2025-03-05
LT3866833T (lt) 2025-04-25
SG11202102340RA (en) 2021-05-28
JP7555915B2 (ja) 2024-09-25
CN112789053A (zh) 2021-05-11
EP3866833A1 (fr) 2021-08-25
CL2022000779A1 (es) 2022-11-25
JOP20210025A1 (ar) 2021-02-07
WO2020079127A1 (fr) 2020-04-23
US20210353717A1 (en) 2021-11-18
PL3866833T3 (pl) 2025-06-23
SI3866833T1 (sl) 2025-06-30
BR112021005019A2 (pt) 2021-06-08
CA3110205A1 (fr) 2020-04-23
HRP20250463T1 (hr) 2025-06-06
MD3866833T2 (ro) 2025-07-31
DK3866833T3 (da) 2025-04-28
AU2019363279B2 (en) 2025-04-03
MX2021004383A (es) 2021-06-04
UA128731C2 (uk) 2024-10-09
MY210133A (en) 2025-08-28
ES3026229T3 (en) 2025-06-10
AU2019363279A1 (en) 2021-03-11
JOP20210025B1 (ar) 2024-12-22
EP3866833B1 (fr) 2025-02-19
US20250325637A1 (en) 2025-10-23
IL280750A (en) 2021-04-29
CL2021000928A1 (es) 2021-10-22
MA53909B1 (fr) 2025-07-31

Similar Documents

Publication Publication Date Title
IL271025A (en) Multibiotic agents and methods of using the same
EP3607072A4 (fr) Compositions et méthodes de traitement de la phénylcétonurie
MA47611A (fr) Compositionset méthodes de transduction tumorale
MA46481A (fr) Compositions d'oligonucléotides et méthodes associées
EP3595653A4 (fr) Compositions de plinabuline et leur utilisation
EP3328363A4 (fr) Compositions et méthodes d'immunomodulation
SI3743406T1 (sl) Modulatorji TMEM16A
MA46102A (fr) Composés de tétracycline et méthodes de traitement
IL283967A (en) Modulators of hsd17b13 expression
EP3355954A4 (fr) Méthodes et compositions d'administration
EP3368077A4 (fr) Compositions et méthodes de transduction tumorale
MA48730A (fr) Compositions et méthodes de traitement de synucléinopathies
IL281492A (en) Modulators of pnpla3 expression
PT3277270T (pt) Composições e métodos de tratamento de anemia
JP2018172409A5 (ja) １５−ｈｅｐｅを含む組成物および同組成物を使用する方法
IL272851A (en) Methods of using dipivefrin
EP3600285A4 (fr) Compositions topiques et méthodes de traitement
MA54143A (fr) Compositions et méthodes
EP3658142A4 (fr) Compositions et méthodes de traitement de la galactosémie
EP3609500A4 (fr) Traitement d'adipocytes
EP3707869A4 (fr) Groupement et utilisation de séquences courtes de signaux
IL313083A (en) Terlipressin compositions and their methods of use
PL3661510T3 (pl) Sposoby leczenia zmian zachowania
EP3298141A4 (fr) Compositions et méthodes de traitement du cancer
IL280343A (en) Treatment of mucopolysaccharidosis iva